These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 11728978

  • 1. Progression of diabetic nephropathy: role of plasma homocysteine and plasminogen activator inhibitor-1.
    Hovind P, Tarnow L, Rossing P, Teerlink T, Stehouwer CD, Emeis JJ, Parving HH.
    Am J Kidney Dis; 2001 Dec; 38(6):1376-80. PubMed ID: 11728978
    [Abstract] [Full Text] [Related]

  • 2. Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function.
    Lajer M, Tarnow I, Michelson AD, Jorsal A, Frelinger AL, Parving HH, Rossing P, Tarnow L.
    Platelets; 2010 Dec; 21(7):525-32. PubMed ID: 20701458
    [Abstract] [Full Text] [Related]

  • 3. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM, Mauer M, International Diabetic Nephropathy Study Group.
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [Abstract] [Full Text] [Related]

  • 4. Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate.
    Astrup AS, Tarnow L, Pietraszek L, Schalkwijk CG, Stehouwer CD, Parving HH, Rossing P.
    Diabetes Care; 2008 Jun; 31(6):1170-6. PubMed ID: 18332153
    [Abstract] [Full Text] [Related]

  • 5. Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case-control study.
    Soedamah-Muthu SS, Chaturvedi N, Teerlink T, Idzior-Walus B, Fuller JH, Stehouwer CD, Eurodiab ProspectivE Complications Study Group.
    J Intern Med; 2005 Nov; 258(5):450-9. PubMed ID: 16238681
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Reduction in albuminuria predicts diminished progression in diabetic nephropathy.
    Rossing P, Hommel E, Smidt UM, Parving HH.
    Kidney Int Suppl; 1994 Feb; 45():S145-9. PubMed ID: 8158884
    [Abstract] [Full Text] [Related]

  • 14. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus.
    Wollesen F, Brattström L, Refsum H, Ueland PM, Berglund L, Berne C.
    Kidney Int; 1999 Mar; 55(3):1028-35. PubMed ID: 10027940
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Association of urinary type IV collagen with GFR decline in young patients with type 1 diabetes.
    Morita M, Uchigata Y, Hanai K, Ogawa Y, Iwamoto Y.
    Am J Kidney Dis; 2011 Dec; 58(6):915-20. PubMed ID: 21763044
    [Abstract] [Full Text] [Related]

  • 19. Urinary albumin excretion rate and its determinants after 6 years in non-insulin-dependent diabetic patients.
    Wirta OR, Pasternack AI, Mustonen JT, Koivula TA, Harmoinen A.
    Nephrol Dial Transplant; 1996 Mar; 11(3):449-56. PubMed ID: 8671814
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.